Family history of MBC and additional primary cancer diagnoses were also not predictive of positive results in this cohort, consistent with current NCCN BRCA1/2 testing guidelines which recommend testing for MBC patients regardless of age at diagnosis or other clinical history. This evidence concerns the gene BRCA1 and cancer.